News & Media Press releases & statements Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Month Year Su Mo Tu We Th Fr Sa 25 26 27 28 29 30 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Cancel OK Year All Years 2022 2021 2020 2019 2018 2017 2016 2015 Category All categories Type - Statement - Press release Topic - Corporate and finance - Partnerships Research area - COVID-19 - Ebola - RSV - Seasonal influenza Uncategorized Keywords Apply filter Advanced Search Search Search Headlines Only Type All Statement Press release Topic All Corporate and finance Partnerships Research area All COVID-19 Ebola RSV Seasonal influenza From To Asset Types Photos Video Audio Documents Events Standard Jan 25, 2016 Corporate and finance Novavax Prices $300 Million of Convertible Senior Notes Due 2023 Download Jan 8, 2016 Corporate and finance Novavax Appoints Jeffrey Stoddard, M.D., Vice President, Medical Affairs Download Jan 6, 2016 Corporate and finance Novavax to Present at the 34th Annual J.P. Morgan Healthcare Conference Download Dec 21, 2015 Corporate and finance Novavax Appoints Mark Twyman Vice President Marketing Download Dec 14, 2015 RSV Novavax Completes Enrollment of Pivotal Phase 3 Trial of the RSV F Vaccine in Older Adults Download Show 5102550100 per page«1…59606162636465…71»